Thanks for the clarification. BTW, given the absurdity and ingeniousness of it all (i.e. Adage), nobody on this board should be remotely surprised to see the pps climb to double-digits again in short order, prior to EMA.
I suspect the Adage folks are probably hedging that this time they need to have a better position when a licensing deal comes out, sooner rather than later.
My, oh my, the volatility of the Bio world is not for the faint of heart or the emotional investor.
Up, up, up we go...
Market Data 
Markets 
AI
